Home > Healthcare > Analytical Instruments > Lab Equipment and Supplies > Serum Separation Gel Market

Serum Separation Gel Market Trends

Report ID: GMI8814
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Serum Separation Gel Market Trends

The ongoing progress in blood testing, which estimated to reach USD 142 billion by 2032, technologies signifies a fundamental change in the methods healthcare providers utilize for collecting and processing patient samples. These advancements encompass various enhancements in collection tube design and the integration of innovative features, all geared towards improving efficiency, preserving sample integrity, and elevating patient comfort.

Technological advancements in blood collection methods such as vacuum-sealed collection tubes or integrated separator systems streamline the sample collection process. This efficiency reduces the time and labor required for sample processing, contributing to overall workflow optimization.
Some innovative blood collection systems enable the collection of smaller sample volumes, ensuring ample serum yield. This decrease in sample volume requirements proves especially advantageous for pediatric or geriatric patients or situations with limited sample availability.
Additionally, advanced blood collection technologies help to minimize the risk of sample hemolysis or contamination ensuring the integrity and purity of serum samples. High-quality samples are crucial for accurate diagnostic testing and reliable results making them essential for healthcare providers and clinical laboratories.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The serum separation gel industry crossed USD 7.7 billion in 2023 and is estimated to reach over USD 13 billion by 2032, driven by the increasing prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and cancer.

The blood banks end-use segment in the serum separation gel industry accounted for USD 3.4 billion in 2023 and is set to gain traction by 2032, owing to the ability to improve the safety and efficacy of blood products collected and processed by blood banks.

North America serum separation gel market held a revenue share of 40.6% in 2023 and is predicted to witness substantial growth by 2032, driven by a well-developed healthcare infrastructure, including state-of-the-art clinical laboratories.

Becton, Dickinson and Company, BIOSIGMA S.p.A., Bio-Rad Laboratories, Inc, Cardinal Health, Inc, Danaher Corporation, FL MEDICAL s.r.l. and Greiner AG among others.